FDA says focused on tracking drugs after approval
ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process. The FDA was responding to critics who say the agency is toothless when it comes to tracking the safety of drugs already on the market, when industry funds that supported pre-approval reviews tend to dry up. "We think we've really balanced this," Dr. ...
Source: news.yahoo.com
No comments:
Post a Comment